Bentley Pharmaceuticals to Present at the UBS Global Specialty Pharmaceuticals Conference on April 25, 2006.EXETER, N.H. -- Bentley Pharmaceuticals, Inc. (NYSE NYSE See: New York Stock Exchange : BNT BNT Bentley Pharmaceuticals, Inc. (stock symbol) BNT Boston Naming Test (psychology) BNT Bermuda National Trust BNT Bulgarian National TV BNT Broadband Network Termination BNT Binary File Transfer ), a specialty pharmaceutical and drug delivery company, announced today that John A. Sedor, President of the Company and Michael Price
Michael F. Price (born 1953) is a value investor and fund manager in Far Hills, New Jersey. , Vice President and CFO See Chief Financial Officer. , will present at the UBS UBS Union Bank of Switzerland UBS United Bible Societies UBS United Blood Services UBS United Buying Service UBS Used Bookstore UBS University Business Services UBS Universal Building Society (UK) UBS Ulaanbaatar Broadcasting System Global Specialty Pharmaceuticals Conference taking place at the Grand Hyatt in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . The presentation is scheduled for Tuesday, April 25, 2006 at 8:00 AM. This presentation will be broadcast live over the Internet and may be accessed via the Company's website, www.bentleypharm.com. In addition, a replay of the presentation will be available on the website, shortly after the presentation. The replay will be archived for 30 days. Bentley Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on advanced drug delivery technologies and pharmaceutical products. Bentley's proprietary drug technologies enhance or facilitate the absorption of pharmaceutical compounds across various membranes. Bentley also manufactures a growing portfolio of generic and branded pharmaceuticals in Europe for the treatment of cardiovascular, gastrointestinal, infectious and neurological diseases through its subsidiary, Laboratorios Belmac, and markets these pharmaceutical products through its subsidiaries, Laboratorios Belmac, Laboratorios Davur, Laboratorios Rimafar and Bentley Pharmaceuticals Ireland; and manufactures and markets active pharmaceutical ingredients through its subsidiary, Bentley API. Copies of Bentley Pharmaceuticals' press releases and other information may be obtained through Bentley's web site at www.bentleypharm.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion